ALKBH2 and colorectal cancer: ABH2 downregulation has been found to inhibit epithelial–mesenchymal transition [122], and a similar regulatory effect has been detected in colorectal cancer cell lines, where an ABH2 knockdown inhibits the proliferation and invasive capacity of colorectal cancer cells through upregulation of E-cadherin and decreased expression of N-cadherin [123].